<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02560155</url>
  </required_header>
  <id_info>
    <org_study_id>14-11-F</org_study_id>
    <nct_id>NCT02560155</nct_id>
  </id_info>
  <brief_title>Preoperative Decolonization and Surgical Site Infections - a Prospective Randomized Trial</brief_title>
  <acronym>DECO-SSI</acronym>
  <official_title>Preoperative Decolonization and Surgical Site Infections - a Prospective Randomized Trial (DECO-SSI Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lindenhof AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Clinical Trials Unit Bern (CTU)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lindenhofstiftung</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Labormedizinisches Zentrum Dr. Risch</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Lindenhof AG</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Surgical site infections are a major postoperative complication and are mostly due to
      colonization with endogenous germs, like Staphylococcus aureus, Staphylococcus epidermidis or
      Propionibacterium acnes. In literature, preoperative decolonization procedures showed a trend
      in lowering surgical site infection rates, but especially in orthopedic surgery data is
      controversial and randomized controlled trials are lacking. In the main study, the study
      investigators aim at performing a controlled prospective randomized interventional trial to
      measure the impact of preoperative decolonization of nasal Staphylococcus aureus carriers on
      surgical site infection rates in orthopedic surgery. In an alongside study a controlled
      prospective randomized interventional trial to measure the impact of preoperative skin
      decolonization of patients undergoing an orthopedic procedure will be conducted.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All participants will be assessed for eligibility during preoperative othopedic consultation.
      2-3 weeks prior operation date participants will be screened for Staph. aureus carriage by
      nose-swab. According to nose-swab results randomizaton and allocation to study arm will be
      performed.

      After one and three months post-operatively participants will be asked by phone interview if
      surgical site infections occured. Results have to be confirmed by orthopedic surgeon if
      possible.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2015</start_date>
  <completion_date type="Actual">February 2018</completion_date>
  <primary_completion_date type="Actual">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall number of participants with surgical site infections 3 months postoperatively</measure>
    <time_frame>3 months</time_frame>
    <description>Phone interview and orthopedic assessement</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants with surgical site infections at 1 and 3 months postoperatively</measure>
    <time_frame>1 and 3 months</time_frame>
    <description>Phone interview and orthopedic assessement</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Total screening costs</measure>
    <time_frame>one year</time_frame>
    <description>Total screening costs divided by the number of prevented SSI to assess cost-effectiveness</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">1300</enrollment>
  <condition>Orthopedic Disorders</condition>
  <condition>Surgical Site Infection</condition>
  <arm_group>
    <arm_group_label>Nose-SA-carriers control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control Group, no intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nose-SA-carriers decolonized</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Chlorhexidine sol 4%; Mupirocin 2% nasal ointement
1 shower/day for 5 days and Nasal ointement 2x/d in each nostril for 5 days preoperatively</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-nose-SA-carriers control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control Group, no intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-nose-carriers decolonized</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Chlorhexidine sol 4% shower, daily for 5 days preoperatively</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mupirocin 2% nasal ointement</intervention_name>
    <description>Mupirocin nasal ointement 2x/d for 5 days preoperatively</description>
    <arm_group_label>Nose-SA-carriers decolonized</arm_group_label>
    <other_name>Bactroban Nasal</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chlorhexidine sol 4%</intervention_name>
    <description>Shower with Chlorhexidine sol 4% once a day for 5 days preoperatively</description>
    <arm_group_label>Nose-SA-carriers decolonized</arm_group_label>
    <arm_group_label>Non-nose-carriers decolonized</arm_group_label>
    <other_name>Lifo-Scrub sol 4%</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient older than 16 years

          -  patient undergoing elective orthopedic procedure at the Sonnenhof hospital

          -  decolozination protocol can be performed timely

          -  signed informed consent

        Exclusion Criteria:

          -  no orthopedic surgery planned

          -  allergy to mupirocin or chlorhexidine

          -  presence of a nasal foreign body

          -  no informed consent

          -  pregnancy

          -  decolozination protocol can't be followed timely

          -  patients undergoing treatment/surgery for a documented infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Br√ºgger, Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lindenhof AG</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sonnenhofspital, Lindenhofgruppe</name>
      <address>
        <city>Bern</city>
        <zip>3006</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 16, 2015</study_first_submitted>
  <study_first_submitted_qc>September 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 25, 2015</study_first_posted>
  <last_update_submitted>February 26, 2018</last_update_submitted>
  <last_update_submitted_qc>February 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Orthopedic surgery</keyword>
  <keyword>Surgical site infection</keyword>
  <keyword>Decolonization</keyword>
  <keyword>Staphylococcus aureus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Surgical Wound Infection</mesh_term>
    <mesh_term>Musculoskeletal Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
    <mesh_term>Mupirocin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

